# Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes

> **NCT02398383** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 7 (actual)

## Conditions studied

- Cystic Fibrosis
- Cystic Fibrosis Related Diabetes

## Interventions

- **OTHER:** Oral Glucose Tolerance Test
- **OTHER:** Mixed Meal Tolerance Test
- **OTHER:** Hypoglycemic Clamp

## Key facts

- **NCT ID:** NCT02398383
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-06-22
- **Final completion:** 2017-06-22
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02398383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02398383, "Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02398383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*